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ABSTRACT
The Gene Ontology (GO) Consortium (GOC, http://
www.geneontology.org) is a community-based bio-
informatics resource that classifies gene product
function through the use of structured, controlled
vocabularies. Over the past year, the GOC has im-
plemented several processes to increase the
quantity, quality and specificity of GO annotations.
First, the number of manual, literature-based anno-
tations has grown at an increasing rate. Second, as
a result of a new ‘phylogenetic annotation’ process,
manually reviewed, homology-based annotations
are becoming available for a broad range of
species. Third, the quality of GO annotations has
been improved through a streamlined process for,
and automated quality checks of, GO annotations
deposited by different annotation groups. Fourth,
the consistency and correctness of the ontology
itself has increased by using automated reasoning
tools. Finally, the GO has been expanded not only to
cover new areas of biology through focused inter-
action with experts, but also to capture greater spe-
cificity in all areas of the ontology using tools for
adding new combinatorial terms. The GOC works
closely with other ontology developers to support
integrated use of terminologies. The GOC supports
its user community through the use of e-mail lists,
social media and web-based resources.
INTRODUCTION
The Gene Ontology (GO; http://www.geneontology.org)
project is a bioinformatics resource that serves as a com-
prehensive source of functional information on gene
products and descriptions of functions through the use
of domain-speciﬁc ontologies (1). The project consists of
a collaborative effort to create evidence-supported gene
product annotations to structured, controlled
vocabularies describing how and where gene products
act. First deﬁned in 1998, the GO has grown to become
an integrated resource containing functional information
for 347 778 species (including strains) covering plants,
animals and the microbial world. GO’s usefulness to the
community is also evident from the number of citations
the inaugural GOC paper, Ashburner et al. (1), has
received: 7637 as of October 2012 (Source: Thomson
Reuters Web of Knowledge). The GOC distributes all an-
notations, vocabularies and tools freely via the Internet. In
order to serve as an authoritative source for these func-
tional annotations, the consortium has made several en-
hancements to its tools and resources and drawn policies
to improve the consistency and currency of annotations.
GUIDELINES FOR GO ANNOTATIONS
The GO annotations are the core product of the GOC.
There are two parts to a GO annotation: ﬁrst, the associ-
ation between a gene product and a descriptive GO deﬁn-
ition; and second, the source and evidence used to make
the link. The descriptive deﬁnitions, which represent an
activity or process or location in the cell of a gene
product, are given a name called the GO term, and a
numerical identiﬁer, the GO ID. Although these associ-
ations are viewed as being made to GO terms they are
made to the descriptive deﬁnitions because sometimes
names of biological concepts or terminology used in the
literature can be ambiguous.
The source of the data is a speciﬁc reference (e.g.
PMID: 20952387) that describes the experiment or
analysis upon which the association was based and an
evidence code such as Inferred from Mutant Phenotype
(IMP), Inferred from Direct Assay (IDA) to reﬂect the
type of study/analysis that supports the association.
There are two methods for making annotations:
manually by curators and computationally by automated
methods. Manual annotations are made by trained
curators from a range of database groups such as
Saccharomyces Genome Database (SGD), Mouse
Genome Informatics (MGI) and UniProtKB (http://
www.geneontology.org/GO.annotation.species_db.shtml).
This method involves reading relevant publications,
identifying the gene product(s) of interest and translating
the results from the study to a GO deﬁnition using an
appropriate evidence code or by inferring a gene
products role by manual examination of its sequence
features. In contrast, automated methods predict func-
tions of genes using a variety of criteria, but mostly by
comparing their sequence to genes with similar sequence
without any manual review.
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As reports of biological data can be subject to interpret-
ation, and the state of biological knowledge is constantly
changing, to maintain consistency in curation, the GOC
has come up with guidelines to help curators interpret
experimental results and map them to the closest GO
term deﬁnition possible (http://www.geneontology.org/
GO.annotation.conventions.shtml). For example, loss of
gene function can cause several phenotypes and often it
can be challenging to determine whether a gene is directly
involved in a process or is involved in an upstream
process, perturbation of which results in the phenotypes
examined. Similarly, it can sometimes be difﬁcult to
discern when a gene product is involved in a biological
process as opposed to regulating the process. Another
area in which the GOC has made improvements is the
use of evidence codes. In order to point users to the ori-
ginal source of the data, during recent years, the GOC has
made efforts to update literature-based annotations to use
experimental evidence codes such as IMP or IDA as
opposed to non-experimental codes such as Traceable
Author Statement (TAS), typically made from Review
articles. The GOC is also working closely with the devel-
opers of the Evidence Code Ontology (ECO, http://www
.ontobee.org/browser/index.php?o=ECO) to formalize
the representation of evidence used in making annota-
tions, a result of which is that the evidence codes currently
used by the GOC have been mapped to ECO identiﬁers.
The next-generation gene association ﬁle format (GPAD
format) will accommodate the ECO identiﬁers.
ANNOTATION SUBMISSION PROCEDURES
AND POLICIES
GO annotations are disseminated in a standard ﬁle format
called the gene_associations ﬁle (GAF 2.0). As more
genomes are being sequenced, more functional annota-
tions are being generated by both the GOC member
groups and external groups and the GOC recognizes the
need to collect, integrate and disseminate all annotations
in a consistent and easy-to-access format. In order to
streamline this process, we have formulated and published
simple guidelines which are available on the GOC website
(http://www.geneontology.org/GO.Submit.Annotation.
shtml). Guidelines are available for groups that want to
submit annotations for a small set of gene products, for an
entire genome or to correct errors in existing annotations.
In addition to the annotations in the standard format, the
GOC also requires a ﬁle that maps the unique database
identiﬁers supplied in participating groups’ gene associ-
ation ﬁles to UniProtKB or NCBI identiﬁers. These ID
mapping ﬁles will allow GOC to provide a robust way to
search for GO annotations using external identiﬁers. More
information on these policies is available online (http://
www.geneontology.org/IDmappingFiles.shtml).
AUTOMATED VALIDATION OF ANNOTATIONS
We have created a rule engine for checking annotations,
ensuring that they conform to annotation guidelines, and
do not contain logical inconsistencies, such as violating a
taxon constraint (2). The engine is driven by a combin-
ation of a conﬁgurable XML (http://www.geneontology
.org/GO.annotation_qc.shtml) and constraints encoded
directly in the ontology.
ANNOTATION PRODUCTION STATUS
As of September 2012, there are over 96 million annota-
tions covering 347 778 species in the GO database.
Of these, 358 319 annotations were made manually
(Table 1). The GOC has seen a steady increase in the
number of manual annotations made by curators
(Figure 1). All annotations can be queried, viewed and
downloaded from AmiGO, the ofﬁcial web-based set of
tools for searching and browsing the GO database (http://
amigo.geneontology.org).
Phylogenetic annotation
The GO Consortium has now established a process for
creating manually reviewed GO annotations using phylo-
genetic inference, which is described in detail elsewhere
(3). A curator views all literature-based experimental
GO annotations for all genes in a family, in the context
of a phylogenetic tree. The curator then integrates all of
this information into a curated, consistent model of
function evolution, which in turn is used to automatically
predict GO annotations for unannotated family members.
These annotations can be identiﬁed by their use of the new
‘‘IBA’’ (inferred from biological aspect of ancestor)
evidence code. For users familiar with annotations using
the ‘‘ISS’’ (inferred from sequence similarity) evidence
code, these new IBA annotations can be thought of as
similar in spirit, though generally based on many pieces
of evidence (multiple annotations across a number of
related genes, a phylogenetic tree showing all evolutionary
relationships, and a multiple sequence alignment) rather
than an isolated pair of related gene products and one
particular annotation. As a result, these IBA annotations
are in general more conﬁdent annotations, and we
encourage users to take advantage of them. We have
also found that this phylogenetic annotation process
improves the quality of experimental GO annotations, as
it has identiﬁed erroneous experimental annotations that
were subsequently removed or corrected. Finally, this
process creates manually reviewed GO annotations for
a number of unannotated genomes. Currently IBA
annotations exist for the 48 species in PANTHER
version 7.2 (4) and will soon be extended to an additional
34 species (see http://www.ebi.ac.uk/reference_proteomes/
for complete list). As of October 2012, the GO database
contained 25,195 annotations with the IBA evidence code,
covering 3,223 genes in 47 species. This number will be
rapidly increasing over the next few years.
DEVELOPMENTS IN AmiGO
To give broad access to the annotations and the
ontologies, several enhancements have been implemented
in AmiGO. AmiGO allows users to browse, visualize,
ﬁlter, and download ontology and annotation data.
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Since the ontologies are growing in size, being able to view
the relationships and terms in a meaningful way has
become a challenge. To address this issue, several alternate
displays of the ontology have been implemented in
AmiGO. Ancestor and children terms of a query term
can be viewed in a tabular format in a tree-like view, or
in multiple graph views (SVG or PNG). Annotations can
be accessed either by navigating through a GO term or by
entering a gene product identiﬁer into the search box. An
Advanced Search form is also available to upload a list of
gene product identiﬁers or GO terms and to constrain the
search by a variety of ﬁlters such as species, data source or
evidence code. Work is underway to provide full access to
all the GO annotations for all the species through
AmiGO.
IMPROVED GO TOOLS REGISTRY
The main GO website (http://www.geneontology.org/GO.
tools.shtml) provides a catalog of software applications
that make use of the GO, including term enrichment
tools. We have improved this catalog by making use of
the Neuroscience Information Framework (NIF) registry
system (5). We now have 130 tools in the registry
(including those developed by external groups), and
provide more extensive metadata on each tool, thanks to
the NIF curators.
ONTOLOGY DEVELOPMENT
To support the creation of annotations, we focused on a
number of interest areas for targeted ontology develop-
ment and we have improved the rigor with which we can
verify and query the ontology computationally as
described below.
Representing Biological Concepts in
the Ontologies
The GOC continues to work with experts in the research
community to expand and reﬁne areas of the ontology.
Typically this process involves face-to-face meeting with
the community experts and the ontology developers to
discuss how best to represent biology in the ontology.
The ontology developers then make changes to the
ontology (edit term strings and deﬁnitions, add or delete
terms) as appropriate to reﬂect the current state of know-
ledge in that area of biology. In the last year, ontology
development focused on apoptosis and cardiac conduc-
tion. A meeting with cardiac experts and the annotation
group at the British Heart Foundation-University
College London, (http://wiki.geneontology.org/index.
php/Cardiac_conduction), resulted in the expansion of
the cardiac conduction portion of the ontology to
include 63 terms that represent processes and functions
that contribute to the regulation of force and strength of
heart contraction. We have also begun a signiﬁcant
top-down overhaul of the apoptosis branch of the
ontology.
The Apoptosis GO project stems from a dual need: a
thorough revision of existing apoptosis-related terms in
GO, and an expansion of the ontology with new terms
to fully capture recent biological knowledge on apoptosis.
The ontology work will be followed by a signiﬁcant anno-
tation and re-curation effort to increase the breadth
Figure 1. Increase in the number of manual GO annotations since 1999. Manual annotations are annotations reviewed by curators.
Table 1. Status of GO as of September 2012
Biological process terms 23 907
Molecular function terms 9459
Cellular component terms 3050
Species with annotation (includes strains) 347 778
Total annotated gene products 96 602 850
Manually annotated gene products 358 319
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(number of gene products) and depth (granularity of the
GO term) of apoptosis-related GO annotations. The
project was initially supported by the APO-SYS
Consortium (Apoptosis Systems Biology Applied to
Cancer and AIDS, http://www.apo-sys.eu/), and took ad-
vantage of direct interaction with expert researchers. At
the time of writing, 75 existing apoptosis GO terms have
been revisited and 60 new GO terms have been created
following discussion with experts. The top-level apoptosis
ontology node has been split to better represent different
sub-processes of the apoptotic process (i.e. signaling
phase, execution phase, changes occurring in the mito-
chondrion and in other sub-cellular compartments, etc.).
The GO now includes speciﬁc terms to represent, e.g.
apoptosis following signaling through dependence
receptors, and caspase activities involved at various steps
of the apoptotic process.
Use of the Web Ontology Language
The Web Ontology Language (OWL) is a standard
provided by the World Wide Web Consortium (W3C) for
representing ontologies and ontology-related information.
OWL is now a crucial component of the GO internal infra-
structure, and provides many advantages to bioinformatics
users of the GO, including standardized Application
Programmer Interfaces (APIs) such as the OWLAPI (6),
standardized means of persistent storage and querying in
RDF triplestores, and fast, powerful reasoners. In order to
take advantage of the features of OWL2, we worked with
members of theOpenBiologicalOntologies (OBO) commu-
nity (7) to create a new version of the mapping between the
GO ontology format (OBO) and OWL (http://oboformat
.org), and a new java implementation of the obo2owl con-
verter. The OWL2 version of the GO is available from a
standard OBO library URL (http://purl.obolibrary.org/
obo/go.owl). We will continue to provide the ontology in
OBO format, but encourage users to consume the OWL
version, and to take advantage of the increasing range
of powerful tooling available for this language.
Logical Definitions
The GO is traditionally thought of as a Directed Acyclic
Graph (DAG), with each term in the ontology represented
as a node (1). OWL extends this model with more expres-
sive constructs, including the ability to provide comput-
able logical deﬁnitions for GO terms, making use of both
simpler GO terms, and terms from other ontologies such
as CHEBI (chemical entities of biological interest) (8).
This provides additional expressive query capabilities for
external users of the GO, and allows the developers of GO
to make use of automated validation and classiﬁcation
procedures (9). Over the past year, ontology editors have
continued to add computable logical deﬁnitions to GO
terms. As of 12 September 2012 there are 12 597 terms
in GO (35%) that have validated logical deﬁnitions. This
includes 8249 terms that reference existing GO terms, and
a further 4348 that reference CHEBI terms. The connec-
tions between GO and CHEBI are now complete for many
part of GO, including metabolism, transport, response to
stimulus and homeostasis. In addition to this fully
validated set of logical deﬁnitions, we have partially
validated logical deﬁnitions that make use of terms from
other ontologies, such as the Cell Ontology (10) the Plant
Anatomy Ontology (11) and the Uberon multi-species
metazoan anatomy ontology (12). The full set is available
from the GOC wiki (http://wiki.geneontology.org/index.
php/Ontology_extensions). The GOC continues to work
with phenotype, cell type, and anatomy ontology
developers, among others, to support alignments and
intersections between community biomedical ontologies.
TermGenie
We previously described our web-based term generation
system TermGenie (13). We have re-implemented this
system on top of the OWL API, and have created
11 standardized templates that allow instant creation of
terms for GO users—this service is available from http://
go.termgenie.org. This takes advantage of the logical
deﬁnitions and OWL reasoning to automatically place
terms in the ontology. For example, an annotator who
requires a term to describe the transport of a particular
molecule simply selects the ‘transport’ template, and
chooses a term from CHEBI.
Automated Ontology Validation
All modiﬁcations to the ontology trigger the GO continu-
ous integration server to launch an extensive validation
procedure, including consistency checking using
powerful OWL reasoners such as HermiT (14) and Elk
(15). This same server is used to perform validation on
the annotations, allowing ontology editors to see the
impact of changes to the ontology upon annotations.
FUTURE DEVELOPMENTS
. GOC will be switching to a SubVersioN (SVN) system
from CVS to manage the dessimination of the
ontology and annotation ﬁle formats.
. GOC is working on implementing InterMine, an open
source data warehouse system with a sophisticated
querying interface to create GOMine. GOMine will
serve as a fast and ﬂexible data retrieval tool with
custom search options and download capabilities.
. Ontology development in the area of cell-cycle is in
progress.
. A new annotation model is being developed to
increase the expressivity (richness) of GO annotations.
ACCESSING DATA AT THE GO CONSORTIUM
(1) GO Consortium—http://www.geneontology.org
(2) AmiGO, the primary web application that provides
access to the annotations and ontologies—http://
amigo.geneontology.org
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(3) Annotations, ontologies and other relevant ﬁles can
be downloaded from the main GO website—http://
www.geneontology.org/GO.downloads.shtml
(4) Documentation on the Gene Association ﬁle format
2.0 can be found at—http://www.geneontology.org/
GO.format.gaf-2_0.shtml
(5) Documentation on several ongoing projects can
be found on the consortium Wiki—http://wiki
.geneontology.org/
(6) Contact GOC at: go-helpdesk@ebi.ac.uk
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